8-K ·Filed Apr 20, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor the company's upcoming proxy filing for the 2026 annual meeting to see if a replacement is named and for any changes in committee composition. No immediate financial impact is expected from this routine board transition.
Final — all horizons settled through T+60d
SCYX ▼ -47.17% at T+60d
NEUTRAL call ✗ call lost -47.17% · α vs SPY -54.07% · entry $8.48 → $4.48
T+1d
-2.83%
call -2.83% · α -3.84%
$8.24
settled 5mo ago
T+5d
-6.98%
call -6.98% · α -8.06%
$7.89
settled 5mo ago
T+20d
-38.02%
call -38.02% · α -42.23%
$5.26
settled 5mo ago
T+60d
-47.17%
call -47.17% · α -54.07%
$4.48
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Steven C. Gilman, a board member of SCYNEXIS Inc., notified the company of his intent to retire and not stand for re-election at the 2026 annual meeting. His departure is due to retirement and not related to any disagreement with the company.
Key Facts
- Dr. Steven C. Gilman is retiring from the Board of Directors and will not stand for re-election at the 2026 annual meeting.
- His term ends upon the conclusion of the 2026 Annual Meeting; he will remain Chair of the Compensation Committee and a member of the Nominating and Corporate Governance Committee until then.
- The company stated the resignation was not due to any disagreement with management, operations, or strategy.
Financial Impact
No direct financial impact disclosed.
Risk Factors
- Potential loss of institutional knowledge given Dr. Gilman's roles as Chair of the Compensation Committee and member of the Nominating and Corporate Governance Committee.
- Governance continuity risk if replacements for key committee roles are not promptly disclosed.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001178253-26-000009 |
| Document: 0001178253-26-000009-index-headers.html | 0001178253-26-000009 |
| Document: 0001178253-26-000009-index.html | 0001178253-26-000009 |
| Document: 0001178253-26-000009.txt | 0001178253-26-000009 |
7 reports for SCYX
100% Hit rate best @ T+20▲ +33.49%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 8-K | $4.70 $4.45 | ▼ −5.32% | ▼ −4.82% | $5.12 (+8.94%) |
Jun 26, 2026 14w ago | 8-K | $3.87 $4.73 | ▲ +22.22% | ▲ +20.83% | $5.12 (+32.30%) |
May 22, 2026 19w ago | 8-K | $5.45 $5.33 | ▼ −2.17% | ▼ −3.25% | $5.12 (−6.02%) |
May 11, 2026 20w ago | Press Release | $6.24 $5.26 | ▲ +15.77% | ▲ +15.17% | $5.12 (+17.95%) |
Apr 20, 2026 23w ago | 8-K | $8.48 $7.89 | ▼ −6.98% | ▼ −8.06% | $5.12 (−39.62%) |
Mar 31, 2026 26w ago | Press Release | $7.34 $7.97 | ▲ +8.62% | ▲ +4.67% | $5.12 (−30.21%) |
Mar 4, 2026 30w ago | Press Release | $6.34 $7.12 | ▲ +12.34% | ▲ +14.58% | $5.12 (−19.24%) |
Showing 7 of 7
US Market Status
Market Closed — Opens Mon (64h 59m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access